BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1024 related articles for article (PubMed ID: 25697705)

  • 1. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease.
    Zhang C; Kuo CC; Moghadam SH; Monte L; Campbell SN; Rice KC; Sawchenko PE; Masliah E; Rissman RA
    Alzheimers Dement; 2016 May; 12(5):527-37. PubMed ID: 26555315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice.
    Dong H; Yuede CM; Yoo HS; Martin MV; Deal C; Mace AG; Csernansky JG
    Neuroscience; 2008 Jul; 155(1):154-63. PubMed ID: 18571864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor receptor 1 activation during exposure to novelty stress protects against Alzheimer's disease-like cognitive decline in AβPP/PS1 mice.
    Scullion GA; Hewitt KN; Pardon MC
    J Alzheimers Dis; 2013; 34(3):781-93. PubMed ID: 23302658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease.
    Dong H; Murphy KM; Meng L; Montalvo-Ortiz J; Zeng Z; Kolber BJ; Zhang S; Muglia LJ; Csernansky JG
    J Alzheimers Dis; 2012; 28(3):579-92. PubMed ID: 22045495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model.
    Zhang C; Kuo CC; Moghadam SH; Monte L; Rice KC; Rissman RA
    J Alzheimers Dis; 2015; 45(2):639-50. PubMed ID: 25649650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
    Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
    Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
    Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
    Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
    Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
    J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stress response neuropeptide CRF increases amyloid-β production by regulating γ-secretase activity.
    Park HJ; Ran Y; Jung JI; Holmes O; Price AR; Smithson L; Ceballos-Diaz C; Han C; Wolfe MS; Daaka Y; Ryabinin AE; Kim SH; Hauger RL; Golde TE; Felsenstein KM
    EMBO J; 2015 Jun; 34(12):1674-86. PubMed ID: 25964433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J; Lauretti E; Craige CP; Praticò D
    J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
    Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
    Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.